Introduction to Molecular Vision
Molecular Vision is an R&D stage in vitro diagnostic company that has developed a technology platform that could radically change how diagnostic tests are administered to patients. The low-cost, instrument-free, disposable point-of-care (PoC) device is able to measure previously incompatible parameters on a single test from a single sample, providing both quantitative and qualitative information.
A spinout of Imperial College London, the Company leverages its expertise in optical detection to measure the light signal change associated with one or several optical parameters in biological assays on its BioLEDTM technology platform. To date, Molecular Vision has validated the flexibility of the platform by multiplexing an albumin and creatinine panel in a urine sample as well as a Myoglobin and CK-MB panel in a serum sample; each panel respectively, on an integrated microfluidic device.
Molecular Vision's prototype fluorescence devices offer sub nanomolar sensitivities in a portable low-cost format. Absorbance and chemiluminescence based detection platforms are currently under development.
London, UK, 13 April 2010
Prof Donal Bradley CBE has been named 2010 recipient of the Institution of Engineering and Technologys IET highest honour the Faraday Medal
Prof. Bradley is to be awarded the Faraday Medal in recognition of his internationally acclaimed contributions to the development of molecular electronic materials and devices. Plastic electronics, as the technology is widely known, embodies a paradigm shift towards low temperature, solution-based device fabrication with applications in energy efficient displays and lighting, photovoltaic energy generation and medical diagnostics.